Bernard Zinman

Sinai Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial”.

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

Diabetes Care(2020)10.2337/dc19-2251

N/A

5.2DataRank · unranked

174 citations

Stephen C. Bain, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock +7 more

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.15260920

N/A

3.4DataRank · unranked

54 citations

Zien Zhou, Hiddo J.L. Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal +18 more

Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

Journal of the American Heart Association(2020)10.1161/jaha.120.016976

N/A

2.4DataRank · unranked

74 citations

Di Xie, Silvio E. Inzucchi, Bernard Zinman, Audrey Koitka‐Weber, Michaela Mattheus +5 more

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Diabetes Care(2020)10.2337/dc20-0279

N/A

1.9DataRank · unranked

61 citations

Robert D. Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire +12 more

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine(2015)10.1056/nejmoa1504720

N/A

1.4DataRank · unranked

11839 citations

Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel +7 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine(2016)10.1056/nejmoa1603827

N/A

1.3DataRank · unranked

7197 citations

Gilbert H. Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F.E. Mann, Michael A. Nauck +13 more

Serum urate and cardiovascular events in the DCCT/EDIC study

Scientific Reports(2021)10.1038/s41598-021-90785-4

N/A

0.421DataRank · unranked

7 citations

Barbara H. Braffett, Arpita Basu, Ionut Bebu, Samuel Dagogo‐Jack, Trevor J. Orchard +86 more

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)

UNC Libraries(2020)10.17615/6t97-gm41

N/A

0DataRank · unranked

0 citations

Richard E. Pratley, Kirstine Brown‐Frandsen, Steven P. Marso, Bernard Zinman, Neil R Poulter +8 more

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

UNC Libraries(2021)10.17615/4ena-v672

N/A

0DataRank · unranked

0 citations

Kirstine Brown Frandsen, Johannes F.E. Mann, John B. Buse, Steven E. Nissen, William M. Steinberg +9 more

Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial

Kidney International(2020)10.1016/j.kint.2020.10.031

N/A

0DataRank · unranked

212 citations

Matthew R. Weir, George L. Bakris, Michaela Mattheus, David Z.I. Cherney, Naveed Sattar +8 more

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Kidney International(2020)10.1016/j.kint.2020.10.042

N/A

0DataRank · unranked

160 citations

Meg Jardine, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan +15 more

Early Benefits of Empagliflozin in Patients with or Without Heart Failure: Findings from EMPA-REG OUTCOME

ESC Heart Failure(2020)10.1002/ehf2.12891

N/A

0DataRank · unranked

20 citations

Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis T. George +4 more

Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

Clinical Kidney Journal(2020)10.1093/ckj/sfaa225

N/A

0DataRank · unranked

18 citations

Mark E. Cooper, Odd Erik Johansen, Robert D. Toto, Julio Rosenstock, Darren K. McGuire +12 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

UNC Libraries(2020)10.17615/5vsp-zn15

N/A

0DataRank · unranked

15 citations

Peter Lommer Kristensen, Lasse Steen Ravn, Richard M. Bergenstal, Stuart Pocock, Neil R. Poulter +10 more

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

UNC Libraries(2020)10.17615/9x50-7b68

N/A

0DataRank · unranked

0 citations

Martin Lange, Bernard Zinman, Kirstine Brown‐Frandsen, Darren K. McGuire, Scott S. Emerson +11 more